SS
Sanjay Dinkar Sawant

Highly Cited

134
Works
1,121
Citations
18
H-Index
Search Authors
Author Statistics
External Links
OpenAlex Profile ORCID Profile

Sanjay Dinkar Sawant

Also known as: Dr. Sanjay D Sawant, S D Sawant, S. D Sawant, S. D. SAWANT, S. D. Sawant

134

Total Works

1,121

Citations

18

H-Index

32

i10-Index

Citation & Works Trend by Year
24 years active
Top Research Topics
Analytical Methods in Pharmaceuticals (36) Fungal Plant Pathogen Control (27) Powdery Mildew Fungal Diseases (22) Pharmaceutical Quality and Counterfeiting (21) Computational Drug Discovery Methods (20)
Recent Publications
15 shown
Year Publication Title Citations Action
2026 Research Writing Techniques: From Idea to Publication Zenodo (CERN European Organization for Nuclear Research) 0
2026 10- Central Composite Design Based New RP-HPLC Method Development and Validation of Tetrabenazine and Identification of Its Degradants by MS Jordan Journal of Pharmaceutical Sciences 0
2026 Network Pharmacology‐Assisted Evaluation of Allium cepa Bulb Phytochemicals in Alopecia: Validation by Molecular Docking and Molecular Dynamics ChemistrySelect 0
2025 New RP-HPLC Method Development and Validation, Incorporating Quality by Design (QbD) with Force Degradation Study for Alectinib Estimation-A Green Approach International Journal of Pharmaceutical Investigation 0
2025 Formulation and Evaluation of Microspheres Loaded with Camellia sinensis (L.) Kuntze Extract for its Antioxidant Potential Current Nutraceuticals 0
2025 Unveiling the Antidiabetic Potential of 6-Chloro-3-(2-substituted-4-oxothiazolidin-3-yl)-2-phenylquinazolin-4(3H)-one Derivatives: Design, Synthesis, and Biological Evaluation Targeting Fructose 1,6-Bisphosphatase with In Silico ADMET and Docking Approaches Russian Journal of Bioorganic Chemistry 1
2025 Unique Quality by Design Approach for Developing High‐Performance Liquid Chromatography and Estimation of Rifaximin and Its Degradants by Mass Spectrometry Separation Science Plus 2
2025 Exploring the Multi-targeted Therapeutic Mechanism of Bioactives from Glycine max in Treatment of type 2 Diabetes Mellitus and Obesity through an In-vitro and In-silico Approach Biosciences Biotechnology Research Asia 1
2025 Green metric-based RP-HPLC method development and validation with force degradation study of neratinib using QbD approach Discover Chemistry. 8
2025 Comprehensive Review and Perspective on Fructose 1,6-Bisphosphatase Inhibitors for the Management of Type 2 Diabetes Mellitus Russian Journal of Bioorganic Chemistry 5
2025 LC–ESI-MS Characterization of Degradents of Brivaracetam; Development and Validation of a Stability-Indicating RP-HPLC Method Research Journal of Pharmacy and Technology 1
2025 QBD-DRIVEN STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF NINTEDANIB ESYLATE International Journal of Applied Pharmaceutics 1
2024 Evaluating the Efficacy and Characterization of Plantago major Extract Microspheres for Novel drug Delivery Research Square 0
2024 ANALYTICAL TECHNIQUES FOR DETERMINATION OF MIRABEGRON FROM BULK, PHARMACEUTICAL FORMULATION, AND BIOLOGICAL MATRICES: A CRITICAL REVIEW International Journal of Applied Pharmaceutics 5
2024 Six-Sigma Model in Pharma Industry: Part – II Springer eBooks 3

Data source: OpenAlex API